Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: A case report and review of the literature

Tumori

Volumn 99, Issue 4, 2013, Pages

  Nader, Kamyar ^a   Mok, Shaffer ^a   Kalra, Ankur ^a   Harb, Antoine ^a   Schwarting, Roland ^a   Ferber, Andres ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Ductopenia; Hodgkin's lymphoma; Vanishing bile duct syndrome

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; CARBOPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; CREATININE; DEXAMETHASONE; GAMMA GLUTAMYLTRANSFERASE; GEMCITABINE; LACTATE DEHYDROGENASE; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; BILE DUCT DISEASE; BILIARY SEPSIS; BILIARY TRACT DISEASE; CASE REPORT; CAUSE OF DEATH; CHOLESTASIS; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; DUCTOPENIA; FATIGUE; FEMALE; FEVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPOTENSION; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; LIVER BIOPSY; LIVER FAILURE; LYMPHADENOPATHY; MIDDLE AGED; NAUSEA; PRURITUS; RETICULOCYTE COUNT; SEPSIS; SEPTIC SHOCK; SHOCK; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VANISHING BILE DUCT SYNDROME; VENTILATOR ASSOCIATED PNEUMONIA;

ALKALINE PHOSPHATASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; CHOLESTASIS; FATAL OUTCOME; FEMALE; HODGKIN DISEASE; HUMANS; HYPERBILIRUBINEMIA; LIVER FAILURE; MIDDLE AGED; SEPSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84890880827     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161309900426     Document Type: Article

References (21)

1. Reau NS, Jensen DM: Vanishing bile duct syndrome. Clin Liver Dis, 12: 203-217, 2008.
2. Hubscher SG, Lumley MA, Elias E: Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatol, 17: 70-77, 1993.
3. Ballonoff A, Kavanagh B, Nash R, Drabkin H, Trotter J, Costa L, Rabinovitch R: Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncologica, 47: 962-970, 2008.
4. Dich NH, Goodman ZD, Klein MA: Hepatic involvement in Hodgkin's disease. Cancer, 64: 2121-2126, 1989.
5. Liangpunsakul S, Kwo P, Koukoulis GK: Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury. Eur J Gastroenterol Hepatol, 14: 323-327, 2001.
6. Nakanuma Y, Tsuneyama K, Harada K: Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobiliary Pancreat Surg, 8: 303-315, 2001.
7. Ludwig J, Wiesner RH, LaRusso NF: Idiopathic adulthood ductopenia, a cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol, 7: 193-199, 1988.
8. Kim WR, Ludwig J, Lindor KD: Variant forms of cholestatic disease involving small bile ducts in adults. Am J Gastroenterol, 95: 1130-1138, 2000.
9. Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, Negrier S, Philip T, Favrot M: Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer, 72: 424-430, 1997.
10. Van den Heuvel MC, de Jong KP, van der Horst ML, Poppema S, Slooff MJ, Gouw AS: Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree. Liver Transpl, 10: 28-35, 2004.
11. Barta SK, Yahalom J, Shia J, Hamlin P: Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma. Clin Lymphoma Myeloma, 7: 77-82, 2006.
12. DeBenedet AT, Berg CL, Enfield KB, Woodford RL: A case of vanishing bile duct syndrome and IBD secondary to Hodgkin's lymphoma. Nat Clin Pract Gastroenterol Hepatol, 5: 49-53, 2008.
13. Rossini MS, Lorand-Metze I, Olivera G, De Souza C: Vanishing bile duct syndrome in Hodgkin's disease: case report. Sao Paulo Med J, 118: 154-157, 2000.
14. Crosbie OM, Crown JP, Nolan NP, Murray R, Hagarty JE: Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease. Hepatology, 26: 5-8, 1997.
15. Leeuwenburgh I, Lugtenburg EPJ, van Buuren HR, Zondervan PE, de Man RA: Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy. Eur J Gastroenterol Hepatol, 20: 145-147, 2008.
16. Guliter S, Erdem O, Isik M, Yamac K, Uluoglu O: Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: report of a case. Tumori, 90: 517-520, 2004.
17. Schmitt A, Gilden DJ, Saint S, Moseley RH: Clinical problem-solving. Empirically incorrect. New Engl J Med, 354: 509-514, 2006.
18. De Medeiros BC, Lacerda MA, Telles JE, da Silva JA, de Medeiros CR: Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome. Haematologica, 83: 1038-1040, 1998.
19. Poupon RE, Poupon R, Balkau R: Ursodiol for the long-term treatment of primary biliary cirrhosis. New Engl J Med, 330: 1342-1347, 1994.
20. Pusl T, Beuers U: Ursodeoxycholic acid treatment of vanishing bile duct syndromes. World J Gastroenterol, 12: 3487-3495, 2006.
21. Lazaridis KN, Gores GJ, Lindor KD: Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J Hepatol, 35: 134-146, 2001.